Unicycive Therapeutics Inc Financial Flexibility Index
Unicycive Therapeutics Inc financial flexibility index. Unicycive Therapeutics Inc (UNCY) has a Financial Flexibility Index of -0.41x as of June 2026. Free cash flow of $-7.60 Million (operating CF $-7.60 Million minus capex $1.00K) represents 0% of total liabilities ($18.76 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Unicycive Therapeutics Inc (2018–2025)
Financial flexibility index of Unicycive Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Unicycive Therapeutics Inc across 8 annual periods. Check cash flow quality index of Unicycive Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Unicycive Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Unicycive Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Unicycive Therapeutics Inc. For the full cash flow conversion analysis, see Unicycive Therapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.65x | $-31.29 Million | $-31.32 Million | $18.94 Million | ▼ -40.5% |
| 2024 | -1.18x | $-28.50 Million | $-28.57 Million | $24.24 Million | ▼ -15.9% |
| 2023 | -1.02x | $-18.27 Million | $-18.28 Million | $18.00 Million | ▲ +78.7% |
| 2022 | -4.77x | $-15.65 Million | $-15.65 Million | $3.28 Million | ▼ -87.7% |
| 2021 | -2.54x | $-5.74 Million | $-5.77 Million | $2.26 Million | ▼ -410.5% |
| 2020 | -0.50x | $-1.43 Million | $-1.46 Million | $2.88 Million | ▲ +60.8% |
| 2019 | -1.27x | $-1.15 Million | $-1.18 Million | $903.00K | ▼ -110.3% |
| 2018 | -0.60x | $-746.00K | $-775.00K | $1.24 Million | — |